NOMAD POWER SOLUTIONS, INC. Increase (Decrease) in Contract with Customer, Liability
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Increase (Decrease) in Contract with Customer, Liability of -$78.58 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2021-03-26
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in contract with customer, liability for fiscal 2020 was -$78.58K, a 199.92% decline from fiscal 2019.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in contract with customer, liability for fiscal 2019 was $78.64K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|
| 2020-12-31 | -$78.58K 10-K · filed 2021-03-26 |
| 2019-12-31 | $78.64K 10-K · filed 2021-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |